Publications by authors named "Berta Torres"

Claim this Profile
I
Incidence, Clinical Features and Vaccination Coverage of Pneumococcal Disease in People Living with HIV: A Retrospective Cohort Study (2015-2024).
Pere Medina, Elisa de Lazzari, Mateu Espasa, Lorena de la Mora, María Martínez-Rebollar, Berta Torres

Vaccines (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?
Abiu Sempere, Rodrigo Alonso, Leire Berrocal, Julia Calvo, Alberto Foncillas, Berta Torres

Infect Dis Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Decades of Change: Evolving Maternal Characteristics and Perinatal Outcomes in Pregnant Women Living with HIV.
Laura Salazar, Anna Goncé, Isabel Matas, Judit Balcells, Laura García-Otero, Berta Torres

Viruses· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Health Outcomes of People with HIV Engaged in Chemsex: A Prospective Cohort Study on Drug Use, Sexual Behaviour, Sexually-Transmitted Infections and Vulnerability.
Lorena De La Mora, Montserrat Laguno, Berta Torres, Ivan Chivite, Alberto Foncillas

Infect Dis Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial.
Elisa de Lazzari, Silvana Di Gregorio, Jhon Rojas, Adria Curran, Pere Domingo, Berta Torres

J Antimicrob Chemother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study.
Elisa de Lazzari, Daniel K Nomah, Jose L Blanco, Naira Rico, Xabier Filella, Berta Torres

Int J Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV.
Montserrat Laguno, Elisa de Lazzari, Leire Berrocal, Alexy Inciarte, Maria Martínez-Rebollar, Berta Torres

HIV Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study.
Ainoa Ugarte, Lorena De La Mora, Elisa De Lazzari, Iván Chivite, Emma Fernández, Berta Torres

J Antimicrob Chemother· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis.
Iván Chivite, Leire Berrocal, Elisa de Lazzari, Soodabeh Navadeh, Carla Lluis-Ganella, Berta Torres

J Antimicrob Chemother· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations.
Alexy Inciarte, Lorena de la Mora, Emilio Huaier-Arriazu, Berta Torres, Silvia Cañizares

Infect Dis Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of raltegravir plus lamivudine maintenance therapy.
Beatriz Borjabad, Alexy Inciarte, Ivan Chivite, Ana Gonzalez-Cordon, Mar Mosquera, Berta Torres

J Antimicrob Chemother· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.
Alba Rocabert, Beatriz Borjabad, Leire Berrocal, Jordi Blanch, Alexy Inciarte, Berta Torres

J Antimicrob Chemother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study.
Adrián Martínez-Serra, Elisa De Lazzari, Leire Berrocal, Alberto Foncillas, Lorena De La Mora, Berta Torres

J Antimicrob Chemother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study.
Lorena De La Mora, Cristina Pitart, Laura Morata, Ainoa Ugarte, María Martinez-Rebollar, Berta Torres

Infect Dis Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).
Alexy Inciarte, Ainoa Ugarte, María Martínez-Rebollar, Berta Torres, Emma Fernández

Open Forum Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study.
Elisa de Lazzari, Leire Berrocal, Emma Fernández, Montserrat Laguno, Iván Chivite, Berta Torres

Medicine (Baltimore)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020.
Sara Toyos, Leire Berrocal, Ana González-Cordón, Alexy Inciarte, Lorena de la Mora, Berta Torres

Euro Surveill· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience.
Ainoa Ugarte, Lorena de la Mora, David García, María Martínez-Rebollar, Elisa de Lazzari, Berta Torres

Infect Dis Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.
Montserrat Laguno, Ainoa Ugarte, María Martinez-Rebollar, Yeray Sobrino, Guillermo Font, Berta Torres

Enferm Infecc Microbiol Clin (Engl Ed)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.
Lorena Usero, Lorna Leal, Carmen Elena Gómez, Laia Miralles, Elena Aurrecoechea, Berta Torres

Vaccines (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain.
Lorena De La Mora, Ainoa Ugarte, Maria Martínez-Rebollar, Elisa De Lazzari, David García-Hernández, Berta Torres

AIDS Behav· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do ART and Chemsex Drugs Get Along? Potential Drug-Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study.
Lorena De La Mora, María J Nebot, Maria Martinez-Rebollar, Elisa De Lazzari, Montserrat Tuset, Berta Torres

Infect Dis Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients.
Verónica Rico-Caballero, Mariana Fernández, Juan C Hurtado, M Angeles Marcos, Celia Cardozo, Berta Torres

Infection· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study.
José L Blanco, Jhon Rojas, Elisa de Lazzari, Alexy Inciarte, Mar Subirana, Berta Torres

J Antimicrob Chemother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study.
María Martínez-Rebollar, Lorena De La Mora, Miriam Campistol, Bruno Cabrera, Albert Bagué, Berta Torres

Infect Dis Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis